Impact of socioeconomic position on initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes – a Danish nationwide observational study

by Alexander C. Falkentoft, Julie Andersen, Mariam Elmegaard Malik, Christian Selmer, Peter Haulund Gæde, Peter Bisgaard Staehr, Mark A. Hlatky, Emil Fosbøl, Lars Køber, Christian Torp-Pedersen, Gunnar H. Gislason, Thomas Alexander Gerds, Morten Schou, Niels E. Bruun, Anne-Christine Ruwald
Published 2022-03-01

MR‐proADM as a Prognostic Marker in Patients With ST‐Segment–Elevation Myocardial Infarction—DANAMI‐3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy...

by Alexander C. Falkentoft, Rasmus Rørth, Kasper Iversen, Dan E. Høfsten, Henning Kelbæk, Lene Holmvang, Martin Frydland, Mikkel M. Schoos, Steffen Helqvist, Anna Axelsson, Peter Clemmensen, Erik Jørgensen, Kari Saunamäki, Hans‐Henrik Tilsted, Frants Pedersen, Christian Torp‐Pedersen, Klaus F. Kofoed, Jens P. Goetze, Thomas Engstrøm, Lars Køber
Published 2018-06-01

Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)

by Martin Schultz, Line Jee Hartmann Rasmussen, Malene H. Andersen, Jakob S. Stefansson, Alexander C. Falkentoft, Morten Alstrup, Andreas Sandø, Sarah L. K. Holle, Jeppe Meyer, Peter B. S. Törnkvist, Thomas Høi-Hansen, Erik Kjøller, Birgitte Nybo Jensen, Morten Lind, Lisbet Ravn, Thomas Kallemose, Theis Lange, Lars Køber, Lars Simon Rasmussen, Jesper Eugen-Olsen, Kasper Karmark Iversen
Published 2018-08-01